Kevin Camphausen, MD

National Cancer Institute (NCI)

BETHESDA, MD

QC-verified· April 2026 PI on 2 trialsNPI: 1043541295

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Anaplastic ependymoma
Gliosarcoma

Clinical trials (2)

NCT01295944
NCT01931098

Verify independently

ClinicalTrials.gov PI search for Kevin Camphausen
NPPES NPI registry entry

Other specialists for Anaplastic ependymoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Maryam Fouladi, MD
COG Phase I Consortium
OH
Amy A Smith
Children's Oncology Group
Jana Portnow, MD
City of Hope Medical Center
CA
Stanislaw R. Burzynski, MD, PhD, M.D., Ph.D
Burzynski Research Institute
TX
David R Grosshans, M.D
NRG Oncology
TX
Sabine Mueller, MD, PhD, MAS, MD, PhD
University of California, San Francisco
CA
Ernest C. Borden, MD
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Elizabeth Fox, MD
National Cancer Institute (NCI)

See all specialists for Anaplastic ependymoma →

← Back to specialists directory